BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA
979 results:

  • 1. Marine seaweed endophytic fungi-derived active metabolites promote reactive oxygen species-induced cell cycle arrest and apoptosis in human breast cancer cells.
    Venkatachalam J; Jeyadoss VS; Bose KSC; Subramanian R
    Mol Biol Rep; 2024 May; 51(1):611. PubMed ID: 38704796
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
    Montaseri H; Abrahamse H
    Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy.
    Munderere R; Gulfam M; Ali I; Kim SH; Vu TT; Park SH; Lim KT
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
    Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
    Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Application of fluorocarbon nanoparticles of
    Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
    J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel lysosome-targeted fluorescent probe for precise formaldehyde detection in water samples, living cells and breast cancer tumors.
    Wang H; Zhang Y; Rong X; Wang B; Wang L; Wang C; Gao W; Ye X; Hou X; Liu W; Wu M; Cheng Y; Shu X; Shang J
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 313():124105. PubMed ID: 38461560
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging.
    Mehata AK; Singh V; Vikas ; Srivastava P; Koch B; Kumar M; Muthu MS
    Nanotheranostics; 2024; 8(2):179-201. PubMed ID: 38444739
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of physical exercise on immune, inflammatory, cardiometabolic biomarkers, and fatty acids of breast cancer survivors: results from the MAMA_MOVE Gaia After Treatment trial.
    Joaquim A; Góis A; Soares A; Garcia C; Amarelo A; Antunes P; Afreixo V; Geraldes V; Capela A; Viamonte S; Alves AJ; Ferreira HB; Guerra I; Afonso AI; Domingues MR; Helguero LA
    Support Care Cancer; 2024 Feb; 32(3):174. PubMed ID: 38378875
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential diagnosis of breast mucinous carcinoma with an oval shape from fibroadenoma based on ultrasonographic features.
    Wang H; Hu Y; Tan C; Gu R; Li Y; Jin L; Jiang X; Mei J; Liu Q; Gong C
    BMC Womens Health; 2024 Feb; 24(1):87. PubMed ID: 38310239
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer.
    Jamali S; Jamali B; Abedi F; Firoozrai M; Davaran S; Vaghefi Moghaddam S
    J Biomater Sci Polym Ed; 2024 Apr; 35(5):605-627. PubMed ID: 38271010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted therapies for breast and lung cancers by using Propolis loaded albumin protein nanoparticles.
    Ghazy MGM; Hanafy NAN
    Int J Biol Macromol; 2024 Mar; 260(Pt 1):129338. PubMed ID: 38232870
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.
    Li X; Zhang Y; Zhu C; Xu W; Hu X; Martínez DAS; Romero JLA; Yan M; Dai Y; Wang H
    BMC Womens Health; 2024 Jan; 24(1):38. PubMed ID: 38218823
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
    Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
    Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification to treat aggressive breast cancer.
    Liu YL; Wang TH; Yeh NT; Huang WJ; Tzang BS; Wu IT; Chin HY; Hu SH; Hsu TC; Chiang WH
    Nanoscale; 2024 Jan; 16(3):1415-1427. PubMed ID: 38167914
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mucilage-assisted fabrication of molybdenum trioxide nanostructures for photothermal ablation of breast cancer cells.
    Alomari RA; Athinarayanan J; Periasamy VS; Alshatwi AA
    Biotechnol Appl Biochem; 2024 Apr; 71(2):326-335. PubMed ID: 38112040
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumour-specific hybrid nanoparticles in therapy of breast cancer.
    Kilicay E; Erdal E; Elci P; Hazer B; Denkbas EB
    J Microencapsul; 2024 Jan; 41(1):45-65. PubMed ID: 38095892
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
    Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
    Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI.
    Li X; Chai W; Sun K; Zhu H; Yan F
    Magn Reson Imaging; 2024 Feb; 106():8-17. PubMed ID: 38035946
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 49.